维普期刊资源整合服务平台（V6.5）

115篇 您的检索式：作者名="LUPU R"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	Membrane-type matrix metalloproteinase-mediated angiogenesis in a fibrin-collagen matrix 显示文摘	Collen A Hanemaaijer R Lupu F	2003	Blood2003，101，5：	2
2	Heregulin-triggered Her-2/neu signaling enhances nuclear accumulation of p21WAF1/CIP1 and protects breast cancer cells from cisplatin-induced genotoxic damage显示文摘	Menendez JA Mehmi I Lupu R	2005	Int J Oncol2005，26，3：	1
3	In Support of Fatty Acid Synthase (FAS) as a Metabolic Oncogene: Extracellu- lar Acidosis Acts in an Epigenetic Fashion Activating FAS Gene Expression in Cancer Cells显示文摘	Menendez JA Decker JP Lupu R	2005	Cell Biochem2005，94，1：	1
4	erbB-2 antisense oligonucleotides inhibit the proliferation of breast carcinoma cells with erbB-2 oncogene amplification显示文摘	Colomer R Lupu R Bacus SS	1994	Br J Cancer1994，70，5：	1
5	The role of erbB2 signal transduction pathways in human breast cancer 显示文摘	Lupu R Lippman ME	1993	Breast Cancer Res Treat1993，27，12：	1
6	The antiobesity drug Orlistat in duces cytotoxic effects, suppresses Her-2/neu (erbB-2) oncogene overexpression, and synergistically interacts with trastuzumab (Herceptin) in chemoresistant ovarian cancer cells 显示文摘	Menendez JA Vellon L Lupu R	2006	Int J Gynecol Cancer2006，16，1：	1
7	erbB-2 antisense oligonucleotides inhibit the proliferation of breast carcinoma cells with erbB-2 oncogene amplification显示文摘	Colomer R Lupu R Bacus S S	1994	Br J Cancer1994，70，5：	1
8	The antiobesity drug Orlistat induces cytotoxic effects,suppresses Her-2/neu (erbB-2) oncogene overexpression,and synergistically interacts with trastuzumab (Herceptin) in chemoresistant ovarian cancer cells显示文摘	Menendez J A Vellon L Lupu R	2006	Int J Gynecol Cancer2006，16，1：	1
9	Membrane-type matrix metalloproteinase-mediated angiogenesis in a fibrin-collagen matrix显示文摘	Hanemaaijer R Lupu F	2003	Blood2003，101，5：	1
10	Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis显示文摘	Menendez JA Lupu R	2007	Nat Rev Cancer2007，7，10：	1
11	Expression and function of Cy61, anangiogenic factor, in bresst cancer cell lines and tumor biopsies显示文摘	Tsai MS Homby AE Lakins J Lupu R	2000	Cancer Res2000，60，：	1
12	Exogenous supplementation with omega-3 polyunsaturated fatty acid docosahexaenoic acid (DHA; 22:6n-3) synergistically enhances taxane cytotoxicity and downregulates Her-2/neu (c-erbB-2) oncogene expression in human breast cancer cells显示文摘	Menendez JA Lupu R Colomer R	2005	Eur J Cancer Prey2005，14，3：	1
13	Targeting fatty acid synthase-driven lipid rafts: a novel strategy to overcome trastuzumab resistance in breast cancer cells显示文摘	Menendez JA Vellon L Lupu R	2005	Medical hypotheses2005，64，5：	1
14	Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis显示文摘	Menendez JA Lupu R	2007	Nat Rev Cancer2007，7，10：	1
15	Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis 显示文摘	Menendez JA Lupu R	2007	Nat Rev Cancer2007，7，10：	1
16	ErbB-2 antisense oligonucleotides inhibit the prolife ration of breast carcinoma cells with erbB-2 oncogene amplification显示文摘	Colomer R Lupu R Bacus SS	1994	Br J Cancer1994，70，：	1
17	Pharmacological inhibitors of Fatty Acid Synthase (FASN)--catalyzed endogenous fatty acid biogenesis: a new family of anti-cancer agents?显示文摘	Lupu R Menendez JA	2006	Curr Pharm Biotechnol2006，7，6：	1
18	Targeting fatty acid synthase in breast and endo- metrial cancer: an alternative to selective estrogen receptor modulators显示文摘	Lupu R Menendez JA	2006	Endocrinology2006，147，9：	1
19	Targeting fatty acid synthase in breast and endometrial cancer: An alternative to selective estrogen receptor modulators显示文摘	Lupu R Menendez JA	2006	Endocrinology2006，147，9：	1
20	Fatty acid synthase and thelipogenic phenotype in cancer pathogenesis显示文摘	Menendez JA Lupu R	2007	Nat Rev Cancer2007，7，10：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示